EnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Kobylyak N.M., Savchenyuk O.A., Virchenko O., Falalyeyeva T.M.

    PATHOPHYSIOLOGICAL ROLE OF ADIPONECTIN IN THE DEVELOPMENT OF OBESITY AND ASSOCIATED DISEASES


    About the author: Kobylyak N.M., Savchenyuk O.A., Virchenko O., Falalyeyeva T.M.
    Heading LITERATURE REVIEWS
    Type of article Review article
    Annotation The analysis of scientific data on the mechanisms of action of adiponectin and its role in metabolism and in the pathogenesis of diseases was represented in this article. It was shown decrease in glucose, triglycerides, low-density lipoprotein level in blood under the influence of adiponectin. Reduced adiponectin concentration in blood was observed in obesity, insulin resistance, nonalcoholic steatohepatitis, atherosclerosis and endothelial dysfunction. Thus, given the range of adiponectin action, activation of intracellular cascades mediated by this hormone creates a field of investigation for search and implementation effective therapeutic agents for the treatment of the above diseases.
    Tags adiponectin, metabolism, obesity, insulin resistance, nonalcoholic steatohepatitis, atherosclerosis
    Bibliography
    • Arita Y.  Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell / Y. Arita, S. Kihara, N. Ouchi [et al.]   // Circulation - 2002, Vol. 105: P.2893–2898.
    • Berg  A. H. ACRP30/ adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab / A.H. Berg, T.P. Combs & T.P. Scherer // - 2002, Vol. 13,  P.84–89.
    • Bobbert T. Changes of adiponectin oligomer composition by moderate weight reduction / T. Bobbert [et al.]  // - 2005, Diabetes 54, P. 2712–2719.
    • Combs T.P. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology / T.P. Combs, U.B. Pajvani, A.H. Berg [et al.]  //- 2004,Vol. 145: P.367–383.
    • Ebinuma H. Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin Chem / H. Ebinuma, T. Miida, T. Yamauchi, [et al.]  // -2007,Vol. 53(8): P. 1541-1544.
    • Gu H.F. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians. Diabetes / H.F. Gu, A. Abulaiti, C.G. Ostenson [et al.]  // - 2004; Vol.53, P.31–35.
    • Hu E. AdipoQ is a novel adipose-specific gene dysregulated in obesity / E. Hu, P. Liang, B.M. Spiegelman [et al.]  // - J Biol Chem -1996; Vol 271: P. 10697–10703.
    • Hotta K. Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus Monkeys. Diabetes / K. Hotta, T. Funahashi, N.L. Bodkin [et al.] // - 2001; Vol. 50, P.1126–1133.
    • Hara K. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes / K. Hara, P. Boutin, Y. Mori [et al.] // - 2002, Vol.51: P.536–540.
    • Hui J.M. Beyond insulin resistance in NASH. TNF-alpha or adiponectin? Hepatology / J.M. Hui, A. Hodge, G.C. Farrell [et al.]  // -  2004, Vol.40: P.46–54.
    • Hug C.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin / C. Hug, J. Wang, N.S. Ahmad [et al.]    //  Proc Natl Acad Sci U S A, - 2004, Vol.101(28): P. 10308-10313.
    • Kubota N. Disruption adiponectin causes insulin resistance neointimal formation. J Biol Chem / N. Kubota, Y. Terauchi, T Yamauchi [et al.]  //- 2002, Vol. 277,  P. 25863–25866.
    • Kamada Y. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology / Y.  Kamada [et al.]  // - 2003, Vol.125: P. 1796–1807.
    • Kobayashi H.   Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin / H. Kobayashi, N. Ouchi, S. Kihara [et al.]  // Circ Res - 2004,Vol. 94(4): P.27-31.
    • Kaser S. Adiponectin and its receptors in non-alcoholic steatohepatitis / S. Kaser, A. Moschen, A. Cayon [et al.]  // Gut - 2005, Vol.54, P. 117–121.
    • Kadowaki T.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome / T. Kadowaki, T. Yamauchi, N. Kubota [et al.]   // J Clin Invest - 2006, Vol. 116(7):P. 1784-92.
    • Kubota N. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab / N. Kubota, W. Yano, T. Kubota [et al.] //  - 2007, Vol. 6(1): P. 55-68.
    • Lopez-Bermejo A. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol Oxf / A. Lopez-Bermejo [et al.]  //-2004, Vol. 60, P. 256–263.
    • Maeda K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). / K. Maeda, K. Okubo, I. Shimomura [et al.] //  Biochem Biophys Res Commun 1996, Vol. 221: P. 286–289.
    • Maeda N. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein / N.  Maeda [et al.]  // Diabetes 50,-2001, P. 2094–2099.
    • Maeda N. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 / N. Maeda, I. Shimomura, K. Kishida [et al.]  //-  Nat Med - 2002, Vol.8, P.731–737.
    • Masaki T.  Adiponectin protects LPSinduced liver injury through modulation of TNF-α in KK-Ay obese mice / T. Masaki [et al.] //  Hepatology- 2004,  Vol. 40: P.177–184.
    • Nakano Y. Isolation and characterization of GBP28, a novel gelatinbinding protein purified from human plasma / Y. Nakano, T. Tobe, N.H. Choi-Miura [et al.]   //- J Biochem (Tokyo) -1996, Vol. 120, P.803–812.
    • Ng T.W. Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? Diabetes / T.W. Ng [et al.] //-2005, Vol. 54, P. 795–802.
    • Nawrocki A.R. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor-γ agonists / A.R. Nawrocki [et al.]  //- J. Biol. Chem - 2006, Vol.281, P.2654–2660.
    • Ouchi N. Novel modulator for endothelial adhesion molecules: adipocytederived plasma protein adiponectin. Circulation / N. Ouchi, S. Kihara, Y. Arita [et al.]  //-1999, Vol. 100, P.2473–2476.
    • Ouchi  N. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages / N. Ouchi, S. Kihara, Y. Arita [et al.]   // Circulation - 2001, Vol.103(8): P. 1057-1063.
    • Okamoto Y. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation / Y.Okamoto, S. Kihara, N. Ouchi [et al.]  //- 2002; Vol. 10, P. 2767–2770.
    • Ouchi N.  Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol / N.Ouchi, S. Kihara, T. Funahashi [et al.]  // - 2003; Vol.14: P.561–566.
    • Pajvani U.B. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity / U.B.  Pajvani, X. Du, T.P. Combs [et al.]   //J Biol Chem, - 2003, Vol. 278(11):P. 9073-9085
    • Pajvani U.B. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity / Pajvani, U. B. [et al.]  // J. Biol. Chem.- 2004, Vol. 279, P. 12152–12162.
    • Resink T.J. LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions / T.J. Resink, Y.S. Kuzmenko, F. Kern [et al.] // FEBS Lett,-1999,Vol.  463(1-2): P. 29-34.
    • Scherer P.E. A novel serum protein similar to C1q, produced exclusively in adipocytes / P.E. Scherer, S. Williams, M. Fogliano, [et al.] // J Biol Chem - 1995, Vol. 270, P. 26746–26749.
    • Shklyaev S. [et al.] (2003) Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats / Shklyaev S. [et al.]  // - 2003,  Proc Natl Acad Sci U S A Vol. 100: P.14217–14222.
    • Shimada K.  Adiponectin and atherosclerotic disease / K. Shimada, T. Miyazaki, H. Daida // Clin Chim Acta - 2004,Vol 344(1-2)P.1-12.
    • Tilg H. Adipocytokines: mediators linking adipose tissue, inflammation and immunity / H. Tilg, A.R. Moschen // Nat Rev Immunol - 2006, Vol. 6(10): P.772-783.
    • Targher G. Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals / G. Targher, L. Bertolini, L. Scala [et al.]  // -2004; Vol.61: P.700–703.
    • Tsuchida A. Insulin/foxo1 pathway regulates expression levels adiponectin receptors adiponectin sensitivity. J Biol Chem / A.Tsuchida, T.Yamauchi, Y. Ito [et al.]  // - 2004, Vol.279: P. 30817–30822.
    • Vasseur F. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocytesecreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet / F.Vasseur, N. Helbecque, C. Dina [et al.] // -  2002, Vol.11: P.2607–2614.
    • Vuppalanchi R. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol / R. Vuppalanchi [et al.]  //- 2005, Vol. 39, P. 237–242.
    • Wolf A.M.   Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun / A.M.Wolf, D.Wolf, H.Rumpold [et al.] // - 2004, Vol. 323, P. 630–635.
    • Waki H. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1/ H. Waki, T. Yamauchi, J. Kamon  [et al.]   // Endocrinology - 2005, Vol. 146(2): P. 790-796.
    • Wan Y. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex / Y.Wang, K.S. Lam, L. Chan [et al.]  // J Biol Chem,2006, Vol. 281(24): P. 16391-16400.
    • Whitehead J.P. [et al.] Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab / J.P.  Whitehead [et al.]  //- 2006,  Vol. 8(3), P.264-280.
    • Xu A. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty  liver diseases in mice. J Clin Invest / A. Xu, Y. Wang, H. Keshaw [et al.]  // - 2003, Vol. 112: P. 91–100.
    • Yokota T.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages / T. Yokota [et al.]  //-  Blood 96 - 2000, P.1723–1732.
    • Yamauchi T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMPactivated protein kinase. Nature Med / T. Yamauchi [et al.]  //-2002, Vol. 8, P.1288–1295.
    • Yamauchi T. [et al.] Cloning of adiponectin receptors that mediate antidiabetic metabolic effects / T. Yamauchi [et al.] //- 2003, Nature 423, P. 762–769.
    • Yamaguchi N.  Adiponectin inhibits Toll-like receptor family-induced signaling / N. Yamaguchi [et al.]  // FEBS Lett - 2005, Vol.579, P. 6821–6826.
    • Yoon Y.S. Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis. Exp Mol Med / Y.S.Yoon, D. Ryu, M.W. Lee [et al.]  // - 2009.
    Publication of the article «World of Medicine and Biology» №3(40) 2 part 2013 year, 081-087 pages, index UDK 616.1/3-02:[577.17:611-018.26]